Nomogram using human epididymis protein 4 predicted concurrent endometrial cancer from endometrial atypical hyperplasia before surgery

ObjectiveTo establish a nomogram based on presurgical predictors of concurrent endometrial cancer (EC) for patients diagnosed with endometrial atypical hyperplasia before definitive surgery (preoperative-EAH) to improve the risk stratification and clinical application.MethodsPreoperative-EAH patient...

全面介紹

書目詳細資料
發表在:Frontiers in Oncology
Main Authors: Yaochen Lou, Feng Jiang, Yan Du, Jun Guan
格式: Article
語言:英语
出版: Frontiers Media S.A. 2024-09-01
主題:
在線閱讀:https://www.frontiersin.org/articles/10.3389/fonc.2024.1442127/full
_version_ 1849860328661188608
author Yaochen Lou
Feng Jiang
Yan Du
Jun Guan
author_facet Yaochen Lou
Feng Jiang
Yan Du
Jun Guan
author_sort Yaochen Lou
collection DOAJ
container_title Frontiers in Oncology
description ObjectiveTo establish a nomogram based on presurgical predictors of concurrent endometrial cancer (EC) for patients diagnosed with endometrial atypical hyperplasia before definitive surgery (preoperative-EAH) to improve the risk stratification and clinical application.MethodsPreoperative-EAH patients who underwent hysterectomy in a tertiary hospital from January 2020 to December 2022 were retrospectively analyzed. Independent predictors from the multivariate logistic regression model were used to establish a nomogram, and bootstrap resampling was used for internal validation.ResultsOf 370 preoperative-EAH patients, 23.4% were diagnosed with EC after definitive surgery (final-EC). Multivariate analyses found three independent predictors of final EC: human epididymis protein 4 (HE4) ≥43.50 pmol/L [odds ratio (OR) = 3.70; 95% confidence intervals (CI) = 2.06–6.67], body mass index (BMI) ≥ 28 kg/m2 (OR = 2.05; 95% CI = 1.14–3.69), and postmenopausal status, particularly at postmenopausal time ≥5 years (OR = 5.84, 95% CI = 2.51–13.55), which were used to establish a nomogram model. The bootstrap-corrected C-index of the nomogram was 0.733 (95% CI = 0.68–0.79), which was significantly higher than that of each individual factor. The calibration curve and decision curve showed good consistency and clinical net benefit of the model. At the maximum Youden index, 49.4% (43/87) of women in the high-risk group defined by nomogram had concurrent EC, versus 16.6% in the low-risk group (P< 0.001).ConclusionThe nomogram based on HE4, menopausal status, and BMI was found with an improved predictive value to stratify preoperative-EAH patients at high risk of concurrent EC for better clinical management.
format Article
id doaj-art-4ded1f0cf6ef4de58d648a62ca019bac
institution Directory of Open Access Journals
issn 2234-943X
language English
publishDate 2024-09-01
publisher Frontiers Media S.A.
record_format Article
spelling doaj-art-4ded1f0cf6ef4de58d648a62ca019bac2025-08-20T01:19:51ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-09-011410.3389/fonc.2024.14421271442127Nomogram using human epididymis protein 4 predicted concurrent endometrial cancer from endometrial atypical hyperplasia before surgeryYaochen Lou0Feng Jiang1Yan Du2Jun Guan3Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, ChinaDepartment of Neonatology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, ChinaClinical Research Unit, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, ChinaDepartment of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, ChinaObjectiveTo establish a nomogram based on presurgical predictors of concurrent endometrial cancer (EC) for patients diagnosed with endometrial atypical hyperplasia before definitive surgery (preoperative-EAH) to improve the risk stratification and clinical application.MethodsPreoperative-EAH patients who underwent hysterectomy in a tertiary hospital from January 2020 to December 2022 were retrospectively analyzed. Independent predictors from the multivariate logistic regression model were used to establish a nomogram, and bootstrap resampling was used for internal validation.ResultsOf 370 preoperative-EAH patients, 23.4% were diagnosed with EC after definitive surgery (final-EC). Multivariate analyses found three independent predictors of final EC: human epididymis protein 4 (HE4) ≥43.50 pmol/L [odds ratio (OR) = 3.70; 95% confidence intervals (CI) = 2.06–6.67], body mass index (BMI) ≥ 28 kg/m2 (OR = 2.05; 95% CI = 1.14–3.69), and postmenopausal status, particularly at postmenopausal time ≥5 years (OR = 5.84, 95% CI = 2.51–13.55), which were used to establish a nomogram model. The bootstrap-corrected C-index of the nomogram was 0.733 (95% CI = 0.68–0.79), which was significantly higher than that of each individual factor. The calibration curve and decision curve showed good consistency and clinical net benefit of the model. At the maximum Youden index, 49.4% (43/87) of women in the high-risk group defined by nomogram had concurrent EC, versus 16.6% in the low-risk group (P< 0.001).ConclusionThe nomogram based on HE4, menopausal status, and BMI was found with an improved predictive value to stratify preoperative-EAH patients at high risk of concurrent EC for better clinical management.https://www.frontiersin.org/articles/10.3389/fonc.2024.1442127/fullhuman epididymis protein 4menopausal statusendometrial cancerendometrial atypical hyperplasiapredictive factor
spellingShingle Yaochen Lou
Feng Jiang
Yan Du
Jun Guan
Nomogram using human epididymis protein 4 predicted concurrent endometrial cancer from endometrial atypical hyperplasia before surgery
human epididymis protein 4
menopausal status
endometrial cancer
endometrial atypical hyperplasia
predictive factor
title Nomogram using human epididymis protein 4 predicted concurrent endometrial cancer from endometrial atypical hyperplasia before surgery
title_full Nomogram using human epididymis protein 4 predicted concurrent endometrial cancer from endometrial atypical hyperplasia before surgery
title_fullStr Nomogram using human epididymis protein 4 predicted concurrent endometrial cancer from endometrial atypical hyperplasia before surgery
title_full_unstemmed Nomogram using human epididymis protein 4 predicted concurrent endometrial cancer from endometrial atypical hyperplasia before surgery
title_short Nomogram using human epididymis protein 4 predicted concurrent endometrial cancer from endometrial atypical hyperplasia before surgery
title_sort nomogram using human epididymis protein 4 predicted concurrent endometrial cancer from endometrial atypical hyperplasia before surgery
topic human epididymis protein 4
menopausal status
endometrial cancer
endometrial atypical hyperplasia
predictive factor
url https://www.frontiersin.org/articles/10.3389/fonc.2024.1442127/full
work_keys_str_mv AT yaochenlou nomogramusinghumanepididymisprotein4predictedconcurrentendometrialcancerfromendometrialatypicalhyperplasiabeforesurgery
AT fengjiang nomogramusinghumanepididymisprotein4predictedconcurrentendometrialcancerfromendometrialatypicalhyperplasiabeforesurgery
AT yandu nomogramusinghumanepididymisprotein4predictedconcurrentendometrialcancerfromendometrialatypicalhyperplasiabeforesurgery
AT junguan nomogramusinghumanepididymisprotein4predictedconcurrentendometrialcancerfromendometrialatypicalhyperplasiabeforesurgery